These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 24858801)
1. CXCL12/CXCR4 axis confers adriamycin resistance to human chronic myelogenous leukemia and oroxylin A improves the sensitivity of K562/ADM cells. Wang Y; Miao H; Li W; Yao J; Sun Y; Li Z; Zhao L; Guo Q Biochem Pharmacol; 2014 Aug; 90(3):212-25. PubMed ID: 24858801 [TBL] [Abstract][Full Text] [Related]
2. Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway. Li X; Miao H; Zhang Y; Li W; Li Z; Zhou Y; Zhao L; Guo Q Arch Toxicol; 2015 Jan; 89(1):121-36. PubMed ID: 24671465 [TBL] [Abstract][Full Text] [Related]
3. Oroxylin A reverses the drug resistance of chronic myelogenous leukemia cells to imatinib through CXCL12/CXCR7 axis in bone marrow microenvironment. Li W; Ding Q; Ding Y; Lu L; Wang X; Zhang Y; Zhang X; Guo Q; Zhao L Mol Carcinog; 2017 Mar; 56(3):863-876. PubMed ID: 27533597 [TBL] [Abstract][Full Text] [Related]
4. Wogonin reverses multi-drug resistance of human myelogenous leukemia K562/A02 cells via downregulation of MRP1 expression by inhibiting Nrf2/ARE signaling pathway. Xu X; Zhang Y; Li W; Miao H; Zhang H; Zhou Y; Li Z; You Q; Zhao L; Guo Q Biochem Pharmacol; 2014 Nov; 92(2):220-34. PubMed ID: 25264278 [TBL] [Abstract][Full Text] [Related]
5. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells. Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283 [TBL] [Abstract][Full Text] [Related]
6. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway. Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia. Zhao L; Li Y; Song X; Zhou H; Li N; Miao Y; Jia L Oncotarget; 2016 Sep; 7(37):60074-60086. PubMed ID: 27527856 [TBL] [Abstract][Full Text] [Related]
8. Silencing of the CrkL gene reverses the doxorubicin resistance of K562/ADR cells through regulating PI3K/Akt/MRP1 signaling. Yu J; Chen WX; Xie WJ; Chen RW; Lin DQ; You WW; Ye WL; Zhang HQ; Lin DH; Xu JP J Clin Lab Anal; 2021 Aug; 35(8):e23817. PubMed ID: 34114685 [TBL] [Abstract][Full Text] [Related]
9. LW-214, a newly synthesized flavonoid, induces intrinsic apoptosis pathway by down-regulating Trx-1 in MCF-7 human breast cells. Pan D; Li W; Miao H; Yao J; Li Z; Wei L; Zhao L; Guo Q Biochem Pharmacol; 2014 Feb; 87(4):598-610. PubMed ID: 24374359 [TBL] [Abstract][Full Text] [Related]
10. Alternation of adriamycin penetration kinetics in MCF-7 cells from 2D to 3D culture based on P-gp expression through the Chk2/p53/NF-κB pathway. Lu M; Zhou F; Hao K; Liu J; Chen Q; Ni P; Zhou H; Wang G; Zhang J Biochem Pharmacol; 2015 Jan; 93(2):210-20. PubMed ID: 25478729 [TBL] [Abstract][Full Text] [Related]
11. [Effects of Compound Zhebei Granule plus doxorubicin on mdr 1 gene expression in nude mice with K562/A02 tumor xenografts]. Zheng Z; Chen J; Li DY; Chen XY Zhong Xi Yi Jie He Xue Bao; 2009 Aug; 7(8):758-62. PubMed ID: 19671415 [TBL] [Abstract][Full Text] [Related]
12. Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo. Li HN; Nie FF; Liu W; Dai QS; Lu N; Qi Q; Li ZY; You QD; Guo QL Toxicology; 2009 Mar; 257(1-2):80-5. PubMed ID: 19135124 [TBL] [Abstract][Full Text] [Related]
13. CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer. Yu X; Shi W; Zhang Y; Wang X; Sun S; Song Z; Liu M; Zeng Q; Cui S; Qu X Sci Rep; 2017 Feb; 7():42226. PubMed ID: 28176874 [TBL] [Abstract][Full Text] [Related]
14. Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway. Gao AM; Ke ZP; Wang JN; Yang JY; Chen SY; Chen H Carcinogenesis; 2013 Aug; 34(8):1806-14. PubMed ID: 23563091 [TBL] [Abstract][Full Text] [Related]
15. Stromal cell-derived factor-1α/C-X-C chemokine receptor type 4 axis promotes endothelial cell barrier integrity via phosphoinositide 3-kinase and Rac1 activation. Kobayashi K; Sato K; Kida T; Omori K; Hori M; Ozaki H; Murata T Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1716-22. PubMed ID: 24925969 [TBL] [Abstract][Full Text] [Related]
16. [Enhancive effect of PLK1 gene silencing on sensitivity of K562/A02 cells to adriamycin]. Liu L; Zhang M; Zou P; Tian L; Liu F Ai Zheng; 2006 Apr; 25(4):404-8. PubMed ID: 16613670 [TBL] [Abstract][Full Text] [Related]
17. Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway. Zhang X; Ai Z; Chen J; Yi J; Liu Z; Zhao H; Wei H Mol Med Rep; 2017 Apr; 15(4):1869-1876. PubMed ID: 28259993 [TBL] [Abstract][Full Text] [Related]
18. Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression. Pan J; Miao D; Chen L Chem Biol Interact; 2018 May; 288():32-37. PubMed ID: 29655913 [TBL] [Abstract][Full Text] [Related]
19. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells. Shi YQ; Qu XJ; Liao YX; Xie CF; Cheng YN; Li S; Lou HX Eur J Pharmacol; 2008 Apr; 584(1):66-71. PubMed ID: 18304528 [TBL] [Abstract][Full Text] [Related]
20. The role of Nrf2 and apoptotic signaling pathways in oroxylin A-mediated responses in HCT-116 colorectal adenocarcinoma cells and xenograft tumors. Hu R; Chen N; Yao J; Zhao Q; Zhang F; Li ZY; You QD; Guo QL Anticancer Drugs; 2012 Jul; 23(6):651-8. PubMed ID: 22526619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]